• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Yuhan makes $325M cancer bet to challenge Boehringer, Takeda

    FIERCE BIOTECH

    Hanmi, LG Chem, Yuhan race to develop new obesity drug

    KOREABIOMED

    Yuhan gets $9.97M milestone payment from Boehringer Ingelheim for NASH therapy

    KOREABIOMED

    Yuhan gets $65m from Janssen for lazertinib milestone achievement

    KOREAHERALD

    Yuhan in-licenses GI Innovation’s allergy treatment pipeline for $1.2b

    KOREAHERALD

    After inking a string of pipeline deals, Boehringer Ingelheim is doing makeover

    ENDPTS

    Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals

    BIOSPACE

    Boehringer Ingelheim and Yuhan Corp. in US$870m NASH deal

    EUROPEAN BIOTECHNOLOGY

    Pfizer plant closures; Gilead-Yuhan NASH pact; Fujifilm expansions

    FIERCE PHARMA

    Glenmark in second licensing deal for anti-histamine

    PRESS RELEASE

    Gilead adds another shot on the NASH goal with $785M Yuhan pact

    FIERCE BIOTECH

    Yuhan, Gilead sign deal to develop new liver drug

    KOREA HERALD

    Gilead stuffs another NASH drug discovery program into a growing portfolio

    ENDPTS

    Yuhan Corporation collaborates with Syntekabio for AI platform

    BIOSPECTRUM

    Top Korean pharma companies increase their R&D spending in H1

    BIOSPECTRUM

    Yuhan Corp. ends licensing partnership with China’s Luoxin Biotech

    KOREA HERALD

    Yuhan Corporation And Sorrento Therapeutics Form Joint Venture Company

    PR NEWS WIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.